Abstract:Deoxyschizandrin is an active lignin ingredient originating from Schisandra chinensis (Turcz.) Baill or Schisandrae Sphenantherae Fructus. In the present study, a novel and efficient strategy was developed for the in vivo screening and identification of deoxyschizandrin metabolites using ultra high performance liquid chromatography combined with triple TOF mass spectrometry (UPLC-TOF/MS/MS). This strategy was characterized by the following: a novel and unique multiple mass defect filter (MMDF) combined with an on-line data acquisition method that is dependent on dynamic background subtraction (DBS) was developed to trace all of the probable metabolites of deoxyschizandrin. The MMDF and DBS methods could trigger an IDA scan for the low-level metabolites that are masked by background noise and endogenous components. A combination of data processing methods including extracted ion chromatography (XIC), mass defect filtering (MDF), product ion filtering (PIF) and neutral loss filtering (NLF) were employed to identify the metabolites of deoxyschizandrin. Next, the structures of the metabolites were elucidated based on an accurate mass measurement, the fragmentation patterns of the parent drug and relevant drug bio-transformation knowledge. Finally, an important parameter ClogP was used to estimate the retention time of isomers. Based on the proposed strategy, 51 metabolites (including 49 phase I and 2 phase II metabolites) were identified in rats after the oral administration of deoxyschizandrin. Among these metabolites, 41 metabolites were characterized in the rat urine, and 28 metabolites were identified in the rat bile. The results indicated that oxidization was the main metabolic pathway and that the methoxy group and the biphenyl cyclooctene were the metabolic sites. Conjugation with sulfate and cysteine groups produced two phase-II metabolites. This study firstly reported the description of deoxyschizandrin metabolism in vivo. This study provided a practical strategy for rapidly screening and identifying metabolites, and this methodology can be widely applied for the structural characterization of the metabolites of other compounds.

Identification of Metabolites of Epimedin A in Rats Using UPLC/Q–TOF–MS

Identification of Metabolites of Crude and Processed Fructus Corni in Rats by Microdialysis Sampling Coupled with Electrospray Ionization Linear Quadrupole Ion Trap Mass Spectrometry.

Determination of Epimedin B in Rat Plasma and Tissue by LC-MS/MS: Application in Pharmacokinetic and Tissue Distribution Studies

Metabolic Profiling of Icariin in Rat Feces, Urine, Bile and Plasma after Oral Administration Using Ultra-High Performance Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry

Liquid chromatography-tandem mass spectrometry analysis of metabolites in rats after administration of prenylflavonoids from Epimediums.

Development and validation of a sensitive liquid chromatography-tandem mass spectrometry method for the assay of 12 substances in rat plasma and its application to rat pharmacokinetics of Epimedium and Psoraleae Fructus herb pair after oral administration

Exploration of the profiles of steroidal saponins from Rhizoma Paridis and their metabolites in rats by UPLC‐Q‐TOF‐MS/MS

The Profiling of the Metabolites of Hirsutine in Rat by Ultra-High Performance Liquid Chromatography Coupled with Linear Ion Trap Orbitrap Mass Spectrometry: an Improved Strategy for the Systematic Screening and Identification of Metabolites in Multi-Samples in Vivo

Systematic analysis of the metabolites of Angelicae Pubescentis Radix by UPLC-Q-TOF-MS combined with metabonomics approaches after oral administration to rats

Rapid classification and identification of chemical constituents in Epimedium koreanum Nakai by UPLC-Q-TOF-MS combined with data post-processing techniques

Pharmacokinetics, Tissue Distribution, and Metabolism Study of Icariin in Rat

Identification of metabolites of Buyang Huanwu decoction in rat urine using liquid chromatography-quadrupole time-of-flight mass spectrometry

Identification and characterization of major alkaloid from Sinomenium acutum stem and their metabolites after oral administration in rat plasma, urine, bile and feces based on UPLC-Q-TOF/MS

Identification of prototype compounds and their metabolites in rats' serum from Xuefu Zhuyu Decoction by UPLC-Q-TOF/MS

Pharmacokinetics study of multiple components absorbed in rat plasma after oral administration of Stemonae radix using ultra-performance liquid-chromatography/mass spectrometry with automated MetaboLynx software analysis

Using UPLC-MS/MS for Characterization of Active Components in Extracts of Yupingfeng and Application to a Comparative Pharmacokinetic Study in Rat Plasma after Oral Administration

Structural elucidation of in vitro metabolites of emodin by liquid chromatography-tandem mass spectrometry

Identification of Metabolites of Deoxyschizandrin in Rats by UPLC–Q-TOF-MS/MS Based on Multiple Mass Defect Filter Data Acquisition and Multiple Data Processing Techniques

Simultaneous Quantification of Multiple Active Components from Xiexin Decoction in Rat Plasma by Lc-Esi-Ms/Ms: Application in Pharmacokinetics

Identification of Lusianthridin Metabolites in Rat Liver Microsomes by Liquid Chromatography Combined with Electrospray Ionization Time-of-flight Mass Spectrometry.